# FDA EIR - Karyopharm Therapeutics Inc. - February 28, 2020

Source: https://www.globalkeysolutions.net/records/eir/karyopharm-therapeutics-inc/bdc34cbe-6742-4e7c-a665-13bee5ed72b3

> FDA EIR for Karyopharm Therapeutics Inc. on February 28, 2020. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Karyopharm Therapeutics Inc.
- Inspection Date: 2020-02-28
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Officers

- [company_representative](https://www.globalkeysolutions.net/people/gary-abernathy/33febbbd-d66f-4ff1-aee7-9a6cef9df794)
- [recipient](https://www.globalkeysolutions.net/people/michael-g-kauffman/450f0644-deb6-4cd4-8fed-6a3eb6a71010)
- [company_representative](https://www.globalkeysolutions.net/people/peter-g-frenkel/4704c7c2-9d9a-4f90-b333-ecf41458ac00)
- [recipient](https://www.globalkeysolutions.net/people/tanya-lewis/4ca03655-1951-49b3-b9f7-f43e1f181e50)
- [company_representative](https://www.globalkeysolutions.net/people/lingling-li/4e672447-5c14-4023-93ca-daeb1a45e40b)

Company: https://www.globalkeysolutions.net/companies/karyopharm-therapeutics-inc/28ffa225-b02c-40a0-8662-5bed25336a5a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c